Hybrid Artificial Pancreas in Home Setting

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Type 1 Diabetes MellitusTreatement by Insulin Pump
Interventions
DEVICE

HYBRID

During the HYBRID Period, the patient will use the AP model when at home, from dinner to wake-up time whereas the patient will self manage glucose control with insulin pump and CGM for the rest of the day.

DEVICE

OPEN

During the control period called OPEN Period, patient self management of diabetes by insulin pump and CGM will be done at all times.

Trial Locations (3)

34000

CHU Montpellier, Montpellier

Unknown

University of Padova, Padua

University of Amsterdam, Amsterdam

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02153190 - Hybrid Artificial Pancreas in Home Setting | Biotech Hunter | Biotech Hunter